Bio

Bio


Dr. Sarah Dubner is a developmental-behavioral pediatrician. The goal of her research is to design interventions that promote healthy development in children at risk for developmental disorders, based on an understanding about how early-life biological and social experiences affect the developing brain.

Dr. Dubner completed her undergraduate degree at Tufts University, where she majored in Physics, her medical degree at the University of Pennsylvania, and pediatric residency at the University of Washington. Following residency, Dr. Dubner practiced as a general pediatrician in the Stanford Divisions of Neonatal and Developmental Medicine and Developmental-Behavioral Pediatrics, before completing subspecialty training in Developmental-Behavioral Pediatrics at Stanford in 2020. During fellowship, she conducted clinical research focused on diffusion MRI tractography measures of brain white matter microstructure and language and cognitive outcomes in children born preterm, under the mentorship of Dr. Heidi Feldman.

Clinical Focus


  • Developmental-Behavioral Pediatrics
  • Neonatology
  • Developmental Behavioral Pediatrics

Academic Appointments


  • Instructor, Pediatrics

Honors & Awards


  • Pediatric Research Loan Repayment Program Award, National Institutes of Health (2018-2020)
  • Tashia and John Morgridge Endowed Postdoctoral Fellow, Clinical Trainee Research Award, Stanford Maternal Child Health Research Institute (2018-2020)
  • Young Investigator Travel Award, Pediatric Academic Societies (2019)
  • Research Grant Award, Society for Developmental-Behavioral Pediatrics (2019-2021)

Boards, Advisory Committees, Professional Organizations


  • Fellow, American Academy of Pediatrics (2011 - Present)

Professional Education


  • Fellowship, Stanford Hospital and Clinics/Stanford Children's Hospital, Developmental-Behavioral Pediatrics (2020)
  • Board Certification: American Board of Pediatrics, Pediatrics (2011)
  • Fellowship: Stanford University Developmental-Behavioral Pediatrics Fellowship (2020) CA
  • Residency: University of Washington Pediatric Residency (2011) WA
  • Medical Education: Perelman School of Medicine University of Pennsylvania (2008) PA
  • Residency, University of Washington, Seattle Children's Hospital, Pediatrics (2011)
  • Medical Education, University of Pennsylvania, School of Medicine (2008)
  • Undergraduate, Tufts University, Physics (2000)

Research & Scholarship

Current Research and Scholarly Interests


Dr. Dubner seeks to design interventions that promote healthy development in children at risk for developmental disorders, based on an understanding about how early-life biological and social experiences affect the developing brain.

Her research objectives are to 1) apply a multimodal approach to understanding modifiable social and biological influences on early human development in at-risk children; 2) design and implement innovative, scalable, and effective interventions to promote child development. Her research strategies include integrating advanced neuroimaging with modern social network analysis and using qualitative and quantitative methods to understand parental social network knowledge and adapting existing evidence-based language health interventions for network-level intervention.

Teaching

Graduate and Fellowship Programs


  • Developmental-Behavioral Pediatrics (Fellowship Program)

Publications

All Publications


  • Trauma, Autism, and Neurodevelopmental Disorders: Integrating Research, Practice, and Policy (Book Review) JOURNAL OF DEVELOPMENTAL AND BEHAVIORAL PEDIATRICS Book Review Authored by: Dubner, S. E., Youssef, J. 2020; 41 (3): 179
  • Reading Abilities in Relation to Quantitative T1 MRI Metrics for Assessing Myelin Content in 8-Year Old Children Born Preterm Travis, K., Dubner, S., Feldman, H. LIPPINCOTT WILLIAMS & WILKINS. 2020: S16
  • White matter microstructure and cognitive outcomes in relation to neonatal inflammation in 6-year-old children born preterm NEUROIMAGE-CLINICAL Dubner, S. E., Dodson, C. K., Marchman, V. A., Ben-Shachar, M., Feldman, H. M., Travis, K. E. 2019; 23
  • Longitudinal Assessment of Bone Density and Structure in an Incident Cohort of Children With Crohn's Disease GASTROENTEROLOGY Dubner, S. E., Shults, J., Baldassano, R. N., Zemel, B. S., Thayu, M., Burnham, J. M., Herskovitz, R. M., Howard, K. M., Leonarda, M. B. 2009; 136 (1): 123-130

    Abstract

    The impact of childhood Crohn's disease (CD) on volumetric bone mineral density (vBMD), bone structure, and muscle mass have not been established. The objective of this longitudinal study was to assess musculoskeletal outcomes in an incident cohort of children with CD using peripheral quantitative computed tomography (pQCT).Tibia pQCT was performed in 78 CD subjects (ages, 5-18 years) at diagnosis and in 67 over the subsequent year. pQCT outcomes were converted to sex- and race-specific z scores based on reference data in over 650 controls. Multivariable linear regression models identified factors associated with changes in bone outcomes.At diagnosis, CD subjects had significant deficits in trabecular vBMD (z score, -1.32+/-1.32; P< .001), cortical section modulus (a measure of bone geometry and strength) (z score, -0.44+/-1.11; P< .01), and muscle (z score, -0.96+/-1.02; P< .001) compared with controls. Over the first 6 months, trabecular vBMD and muscle z scores improved significantly (both, P< .001); however, section modulus worsened (P= .0001), and all 3 parameters remained low after 1 year. Increases in muscle z scores were associated with less severe declines in cortical section modulus z scores. Improvements in trabecular vBMD z scores were greater in prepubertal subjects. Glucocorticoids were associated with increases in cortical vBMD.Substantial deficits in trabecular vBMD, cortical bone geometry, and muscle were observed at CD diagnosis. Trabecular vBMD improved incompletely; however, cortical deficits progressed despite improvements in muscle. Glucocorticoids were not associated with bone loss. Therapies to improve bone accrual in childhood CD are needed.

    View details for DOI 10.1053/j.gastro.2008.09.072

    View details for Web of Science ID 000262028500020

    View details for PubMedID 19026647

    View details for PubMedCentralID PMC2705767

  • Bone density, structure, and strength in juvenile idiopathic arthritis ARTHRITIS AND RHEUMATISM Burnham, J. M., Shults, J., Dubner, S. E., Sembhi, H., Zemel, B. S., Leonard, M. B. 2008; 58 (8): 2518-2527

    Abstract

    To identify determinants of musculoskeletal deficits (muscle cross-sectional area [mCSA], trabecular volumetric bone mineral density [vBMD], and cortical bone strength [section modulus]) in patients with juvenile idiopathic arthritis (JIA) and to determine if cortical bone strength is appropriately adapted to muscle forces.Peripheral quantitative computed tomography (pQCT) of the tibia was performed in 101 patients with JIA (79% female; 24 with oligoarticular JIA, 40 with polyarticular JIA, 18 with systemic JIA, and 19 with spondylarthritis [SpA]) and 830 healthy control subjects; all were ages 5-22 years. Outcomes of pQCT were expressed as sex- and race-specific Z scores. Multivariable linear regression models assessed mCSA and bone status in JIA patients compared with controls and identified factors associated with musculoskeletal deficits in JIA.The median duration of JIA was 40 months; 29% of the JIA patients had active arthritis, and 28% had received glucocorticoid therapy during the previous year. Compared with the controls, the mCSA and section modulus Z scores were significantly lower in patients with polyarticular JIA and those with SpA. Trabecular vBMD Z scores were significantly lower in patients with polyarticular JIA, those with systemic JIA, and those with SpA. Significant predictors of musculoskeletal deficits included active arthritis in the previous 6 months (mCSA), temporomandibular joint disease (mCSA and section modulus), functional disability (mCSA and vBMD), short stature (vBMD), infliximab exposure (vBMD), and JIA duration (section modulus). The section modulus was significantly reduced relative to mCSA in patients with JIA after adjustment for age and limb length.Marked deficits in vBMD and bone strength occur in JIA in association with severe and longstanding disease. Contrary to the findings of previous studies, bone deficits were greater than expected relative to the mCSA, which illustrates the importance of adjusting for age and bone length.

    View details for DOI 10.1002/art.23683

    View details for Web of Science ID 000259055400037

    View details for PubMedID 18668565

    View details for PubMedCentralID PMC2705769

  • Assessment of spine bone mineral density in juvenile idiopathic arthritis: Impact of scan projection JOURNAL OF CLINICAL DENSITOMETRY Dubner, S. E., Shults, J., Leonard, M. B., Zemell, B. S., Sembhi, H., Burnham, J. M. 2008; 11 (2): 302-308

    Abstract

    Although children with juvenile idiopathic arthritis (JIA) are at risk for vertebral fractures, recent conventional posterior-anterior (PA) spine dual-energy X-ray absorptiometry studies reported minimal areal bone mineral density (aBMD, g/cm2) deficits. Width-adjusted BMD (WA-BMD, g/cm3) represents the bone mineral content (BMC) from the lateral projection, excluding the dense cortical spinous processes, divided by the estimated vertebral body volume based on paired PA-lateral bone dimensions. Therefore, WA-BMD may be more sensitive to JIA effects on the predominantly trabecular vertebral body. Age- and sex-specific Z-scores for spine aBMD and WA-BMD were generated in 84 JIA subjects compared with healthy controls, aged 5-21 yr. JIA was associated with lower mean WA-BMD Z-scores (-0.78, 95% CI: -1.03, -0.53; p<0.001) and aBMD Z-scores (-0.26, 95% CI: -0.49, -0.02; p<0.05), compared with controls. WA-BMD Z-scores were significantly lower than aBMD Z-scores in JIA (p<0.001). A significant JIA by age interaction (p<0.001) indicated that the magnitude of the difference between WA-BMD and aBMD Z-scores was greater in younger subjects. In conclusion, WA-BMD may be more sensitive to disease effects in children because it selectively measures the trabecular-rich vertebral body and is independent of growth-related changes in BMC of the dense spinous processes.

    View details for DOI 10.1016/j.jocd.2007.10.005

    View details for Web of Science ID 000256640900012

    View details for PubMedID 18164636

Footer Links:

Stanford Medicine Resources: